Ely Benaim

1.8k citations

75 papers · 1.3k indexed · h-index 21

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Genetics top 5%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment

Papers in

Hematology 21
- Hematopoietic Stem Cell Transplantation 17
Oncology 33
- Pancreatic and Hepatic Oncology Research 9
- Cancer-related Molecular Pathways 8
- Cancer Immunotherapy and Biomarkers 6

Co-authors: Brian P. Sorrentino Jacques Galipeau Wing Leung Edwin M. Horwitz Rupert Handgretinger Kevin D. Bunting Paul Woodard David J. Topham
Journals: Journal of Clinical Oncology (24 papers)Blood (11 papers)Annals of Oncology (4 papers)Bone Marrow Transplantation (4 papers)British Journal of Haematology (3 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Ely Benaim

68 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ely Benaim

Since Specialization

Citations

This map shows the geographic impact of Ely Benaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ely Benaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ely Benaim more than expected).

Fields of papers citing papers by Ely Benaim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ely Benaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ely Benaim. The network helps show where Ely Benaim may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ely Benaim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ely Benaim Line = papers co-authored together Ely Benaim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Interim report of a phase 2 study of sonodynamic therapy (SDT) using SONALA-001 together with MR-guided low-intensity focused ultrasound (MRgFUS) in children with diffuse intrinsic pontine glioma (DIPG). Journal of Clinical Oncology ·Lindsay Kilburn, Roger J. Packer, Adriana Fonseca, Robert F. Keating, Sabine Mueller, Kazim Narsinh, Winson S. Ho, Toba N. Niazi, Takeshi Tohgasaki, สมาน เหล่าดํารงชัย, K Dolmierska, 久徳藤田, Corina Andresen, Stuart G. Marcus, Ely Benaim, Mohd Zaid Abdul Kadir	2024	0
2	A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma Investigational New Drugs ·Hani M. Babiker, Kevin, 傅赞, Andrea J. Bullock, Loredan Mikša, Daruka Mahadevan, Emad Elquza, Mitesh J. Borad, Ely Benaim, Christine B. Peterson, Vinay Shankar Swaminathan, Allyson J. Ocean	2021	4
3	RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer BMC Cancer ·John J. Tentler, Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young Bok Lee, Andrew Eisen, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Sarah Yanosy Sreedhar, Todd M. Pitts, Roberta Pelanda, S. Gail Eckhardt, Jennifer R. Diamond	2020	21
4	First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Anna Capasso, Stacey M. Bagby, Barbara Polnick, Naomi Currimjee, Betelehem W. Yacob, 周腾耀, 崇之藤田, Deog Joong Kim, Matthias Jean Tartarin, Young Bok Lee, Ely Benaim, Sarah Yanosy Sreedhar, Sarah J. Hartman, Aik Choon Tan, Jihye Kim, Todd M. Pitts, S. Gail Eckhardt, John J. Tentler, Jennifer R. Diamond	2019	27
5	Phase 1 study of RX-5902, a novel orally bioavailable inhibitor of phosphorylated P68, which prevents β-catenin translocation in advanced solid tumors Annals of Oncology ·Jennifer R. Diamond, Gail Eckhardt, Maxim Baltin, Martin Gutierrez, Christine B. Peterson, Moti Ayoun, Ely Benaim	2017	5
6	RX-3117, a novel hypomethylating agent, shows promising therapeutic activity in combination with nab-paclitaxel and check-point inhibitors in preclinical models Annals of Oncology ·Jill S. Frank, LeeAnn Madrid, Hanane Sayad, Ely Benaim	2017	2
7	RX-5902: A phosphorylated p68 targeting agent to treat subjects with advanced solid tumors. Journal of Clinical Oncology ·Martin Gutierrez, S. Gail Eckhardt, William Larry Gluck, Ely Benaim	2016	2
8	Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia Investigational New Drugs ·Kevin R. Kelly, Thomas C. Shea, André Goy, Jesús G. Berdeja, Craig B. Reeder, Kevin T. McDonagh, Xiaofei Zhou, Hadi Danaee, Hua Liu, Jeffrey Ecsedy, Huifeng Niu, Ely Benaim, Swaminathan P. Iyer	2013	61
9	Rapid immune reconstitution after a reduced‐intensity conditioning regimen and a CD3‐depleted haploidentical stem cell graft for paediatric refractory haematological malignancies British Journal of Haematology ·Xiaohua Chen, Gregory A. Hale, Raymond Barfield, Ely Benaim, Wing Leung, James Knowles, Edwin M. Horwitz, Paul Woodard, Kimberly A. Kasow, Usman Yusuf, Frederick G. Behm, Randall T. Hayden, Sheila Shurtleff, Victoria Turner, Deo Kumar Srivastava, Rupert Handgretinger	2006	71
10	Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis Bone Marrow Transplantation ·Paul Woodard, Abigail Moore, Huey G. McDaniel, Raja B. Khan, Víctor H. Villauso, G Hale, Ely Benaim, Kimberly A. Kasow, Wing Leung, Edwin M. Horwitz, Deo Kumar Srivastava, Xin Tong, Usman Yusuf, J. M. Cunningham, Rupert Handgretinger	2004	16
11	Etiology and Outcome of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant Recipients Journal of Pediatric Hematology/Oncology ·Paul Woodard, Xin Tong, 昌男吉川, Deo Kumar Srivastava, Edwin M. Horwitz, Ely Benaim, Terrence L. Geiger, Gregory A. Hale, Wing Leung, Victoria Turner, Usman Yusuf, John M. Cunningham, Rupert Handgretinger	2003	26
12	T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation British Journal of Haematology ·Eric Lowe, Victoria Turner, Rupert Handgretinger, Edwin M. Horwitz, Ely Benaim, Gregory A. Hale, Paul Woodard, Wing Leung	2003	105
13	Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia Bone Marrow Transplantation ·Paul Woodard, John M. Cunningham, Ely Benaim, Kyungja Han, G Hale, Edwin M. Horwitz, James Houston, Kimberly A. Kasow, Wing Leung, 葵濱頭, Usman Yusuf, Rupert Handgretinger	2003	30
14	Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL Cytotherapy ·John T. Sandlund, LC Bowman, HE Heslop, Robert A. Krance, H Mahmoud, Ching‐Hon Pui, G Hale, Ely Benaim	2002	19
15	Open lung biopsy in pediatric bone marrow transplant patients Journal of Pediatric Surgery ·Andrea Hayes‐Jordan, Ely Benaim, 昌男吉川, 姚佳红, Dhiraj Kumar Srivastava, Laura C. Bowman, Stephen J. Shochat	2002	48
16	T Cell Immunotherapeutic Populations Control Viral Infections in Bone Marrow Transplant Recipients Immunologic Research ·Karen S. Slobod, Ely Benaim, G. Bohmann, Tina Rahmadayanti, Jim Houston, H.-K. Wang, Timothy Lockey, Julia L. Hurwitz	2001	6
17	Improved cerebrovascular patency following therapy in patients with sickle cell disease: Initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts Annals of Neurology ·R. Grant Steen, Kathleen J. Helton, Edwin M. Horwitz, Ely Benaim, Stephen J. Thompson, Laura C. Bowman, Robert A. Krance, Winfred C. Wang, John M. Cunningham	2001	31
18	Effects of Retroviral‐Mediated MDR1 Expression on Hematopoietic Stem Cell Self‐Renewal and Differentiation in Culture^a Annals of the New York Academy of Sciences ·Kevin D. Bunting, Jacques Galipeau, David J. Topham, Ely Benaim, Brian P. Sorrentino	1999	22
19	Primary central nervous system lymphoma in a child with acute B‐cell lymphoblastic leukaemia: consecutive Epstein‐Barr virus‐related malignancies British Journal of Haematology ·Steven C. Buckingham, Ely Benaim, John T. Sandlund, Yan‐jun Gan, Pamela Freiden, Fred G. Behm, Raul C. Ribeiro, John W. Sixbey, Karen S. Slobod	1998	3
20	A Bicistronic Retroviral Vector for Protecting Hematopoietic Cells Against Antifolates and P-Glycoprotein Effluxed Drugs Human Gene Therapy ·Jacques Galipeau, Ely Benaim, H. Trent Spencer, Raymond L. Blakley, Brian P. Sorrentino	1997	40

About Ely Benaim

Ely Benaim is a scholar working on Hematology, Oncology, Genetics, Cell Biology and Cancer Research, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (17 papers), Microtubule and mitosis dynamics (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Cancer-related Molecular Pathways (8 papers), RNA modifications and cancer (7 papers), Glioma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Hematology (445 citations), Genetics (218 citations), Immunology (320 citations), Oncology (412 citations) and Genetics (239 citations). Ely Benaim has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Brian P. Sorrentino, Jacques Galipeau, Wing Leung, Edwin M. Horwitz, Rupert Handgretinger, Kevin D. Bunting, Paul Woodard, David J. Topham, Gregory A. Hale and Deo Kumar Srivastava. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Bone Marrow Transplantation and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact